CASE REPORT
Published on 05 Jun 2025
Continuous remission of single-mode therapy with pembrolizumab plus chemotherapy in locally advanced hypopharyngeal carcinoma: a case report
doi 10.3389/fimmu.2025.1557565
- 1,149 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Immune-Checkpoint Inhibitors and Immunometabolic Reprogramming in Cancer Immunotherapy
Immune-Checkpoint Inhibitors and Immunometabolic Reprogramming in Cancer Immunotherapy
9,889
Total downloads
35k
Total views and downloads
Articles
CASE REPORT
Published on 30 May 2025
Case Report: Regenerative hepatic pseudotumor induced by tislelizumab in a lung cancer patient
doi 10.3389/fimmu.2025.1565065
- 799 views
ORIGINAL RESEARCH
Published on 27 May 2025
Low dose radiotherapy combined with immune checkpoint inhibitors induces ferroptosis in lung cancer via the Nrf2/HO-1/GPX4 axis
doi 10.3389/fimmu.2025.1558814
- 1,189 views
CORRECTION
Published on 16 May 2025
Corrigendum: Efficacy and safety of PD-1/PD-L1 inhibitors as first-line treatment for esophageal squamous cell carcinoma: a systematic review and meta-analysis
doi 10.3389/fimmu.2025.1611591
- 558 views
REVIEW
Published on 28 Apr 2025
ICI-induced cardiovascular toxicity: mechanisms and immune reprogramming therapeutic strategies
doi 10.3389/fimmu.2025.1550400
- 1,699 views
REVIEW
Published on 28 Apr 2025
Revealing the mechanisms and therapeutic potential of immune checkpoint proteins across diverse protein families
doi 10.3389/fimmu.2025.1499663
- 1,188 views
SYSTEMATIC REVIEW
Published on 26 Mar 2025
Efficacy and safety of PD-1/PD-L1 inhibitors as first-line treatment for esophageal squamous cell carcinoma: a systematic review and meta-analysis
doi 10.3389/fimmu.2025.1563300
- 2,825 views
CASE REPORT
Published on 24 Mar 2025
Successful treatment of an elderly patient with lung squamous cell carcinoma by tislelizumab and chemotherapy: a case report with novel imaging findings
doi 10.3389/fimmu.2025.1543114
- 1,215 views
SYSTEMATIC REVIEW
Published on 11 Mar 2025
Effectiveness and safety of ICIs for the treatment of advanced CC: a systematic review and meta-analysis
doi 10.3389/fimmu.2025.1542850
- 1,403 views
ORIGINAL RESEARCH
Published on 07 Feb 2025
NOX4 modulates breast cancer progression through cancer cell metabolic reprogramming and CD8+ T cell antitumor activity
doi 10.3389/fimmu.2025.1534936
- 2,139 views
- 1 citation
OPINION
Published on 10 Dec 2024
Revisiting immune checkpoint inhibitors: new strategies to enhance efficacy and reduce toxicity
doi 10.3389/fimmu.2024.1490129
- 1,877 views
- 8 citations
SYSTEMATIC REVIEW
Published on 18 Oct 2024
Prognostic value of inflammatory markers NLR, PLR, LMR, dNLR, ANC in melanoma patients treated with immune checkpoint inhibitors: a meta-analysis and systematic review
doi 10.3389/fimmu.2024.1482746
- 2,260 views
- 8 citations
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore